SLX4IP promotes RAP1 SUMOylation by PIAS1 to coordinate telomere maintenance through NF-κB and Notch signaling

Area of Science:

• Cell Biology
• Molecular Oncology
• Cancer Research

Background:

• Telomere length maintenance is crucial for cell division and is implicated in cancer development.
• Telomeres are extended via telomerase or the alternative lengthening of telomeres (ALT) pathway.
• Understanding telomere regulation is key to developing novel cancer therapies.

Purpose of the Study:

• To elucidate the role of the telomere-associated protein SLX4IP in regulating telomere length and cellular signaling.
• To identify the molecular mechanisms by which SLX4IP influences telomere maintenance pathways.
• To explore the therapeutic potential of targeting the SLX4IP-mediated axis in cancer.

Main Methods:

• Investigated the interaction between SLX4IP, PIAS1, and RAP1 at telomeres.
• Analyzed the SUMOylation of RAP1 by PIAS1 and its effect on RAP1-TRF2 interaction.
• Examined the nucleocytoplasmic shuttling of RAP1 and its downstream effects on IKK, NF-κB, and Jagged-1 expression.
• Assessed the impact of this pathway on Notch signaling and ALT in cancer cells.

Main Results:

• SLX4IP recruits and activates PIAS1, leading to SUMOylation of RAP1.
• SUMOylated RAP1 dissociates from TRF2 and translocates to the cytosol.
• Cytosolic RAP1 activates IKK, leading to NF-κB activation and Jagged-1 induction.
• This pathway promotes Notch signaling and the ALT mechanism, contributing to cancer progression.

Conclusions:

• SLX4IP controls telomere proteome composition and directly links telomere maintenance to intracellular signaling.
• The identified SLX4IP-PIAS1-RAP1-NF-κB axis is critical for ALT pathway activation.
• This pathway represents a promising therapeutic target for ALT-driven cancers and treatment-resistant tumors.